Arbli (losartan) – New drug approval
March 13, 2025 - The FDA approved Scienture’s Arbli (losartan) oral suspension, for the:
- Treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure
- Reduction of stroke risk in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients
- Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension.
Top